Genomics Sales Specialist, Quantabio (Northeast Region)
QIAGEN | |
United States | |
Jul 29, 2026 | |
|
Overview At QIAGEN, we are driven by a simple but powerful vision: making improvements in life possible. We're dedicated to revolutionizing science and healthcare for the better. From our entrepreneurial roots to our current global presence, we've grown into a force for positive change. With thousands of employees across six continents, collaboration is our greatest strength. We're always striving to identify talented individuals to join our exceptional teams. At QIAGEN, every day is an opportunity to make a real-life impact. Join us, grow with us, and together, let's shape the future of biological discovery. About the opportunity We are seeking a Genomics Sales Specialist remote-based in Philadelphia, DC or Boston area to support our Quantabio brand portfolio, including NGS, qPCR, and PCR reagents. This individual will have a sales territory encompassing the Northeastern US states. The Quantabio sales team offers and supports a specialized genomics portfolio that operates independently from the broader QIAGEN product portfolio. The ideal candidate will have a strong understanding of Next Generation Sequencing (NGS) and qPCR technologies, along with the ability to effectively communicate technical concepts to a wide range of scientific audiences. Your tasks include
Your profile
Travel requirements
What we offer
Our people are the heartbeat of everything we do. Passion drives us as we push boundaries to innovate and evolve.We inspire with our leadership and make an impact with our actions.We cultivate a collaborative, supportive environment where each individual and team can flourish. We champion accountability and encourage entrepreneurial thinking. QIAGEN is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, sex, age, national origin, religion, sexual orientation, gender identity, status as a veteran, or disability. | |
Jul 29, 2026